GLUE Monte Rosa Therapeutics, Inc.

NASDAQ

$11.77

Monte Rosa Therapeutics, Inc. (GLUE) Earnings News

Earnings press releases, previews and reviews for Monte Rosa Therapeutics, Inc. (GLUE), newest first.

Thursday August 6, 2026 7:00 AM ET

Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Thursday May 7, 2026 7:00 AM ET

Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates